Pituitary & hypothalamus

Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center

PituitaryPublished Retrospective cohort study

Authors' conclusion

PA in FPA has distinct features and management issues. Carefully selected patients (PAS guided) in NFPA with PA for conservative management have comparable outcomes to surgery.

Study context

Population
Patients with pituitary apoplexy managed at a tertiary endocrine centre33.3% functioning pituitary adenoma (FPA)
Participants
93 patients
Exposure
Pituitary apoplexy in FPA vs NFPA; surgical vs conservative management
Outcome
Features and management of pituitary apoplexy
Methodological detailssingle-centre, record review
  • Single-centre
  • Record review

Main finding

As reported in the abstract

Median age, years
40
Type A (acute) presentation
49.5%
Headache
78.5%
Pituitary apoplexy (PA) as initial manifestation in NFPA
98.4%
Median (range) Pituitary Apoplexy Score (PAS)
2 (0-8)
Median tumour diameter
2.5 cm
Larger tumours in FPA vs NFPA
3.2 cm vs. 2.3 cm
Conservatively managed, NFPA
29 (46.7%)
Conservatively managed, FPA (71% prolactinoma, 33% Cushing's Disease (CD), none acromegaly)
14 (45.2%)

Observational data: associations, not effects.

Further findings

NFPA: surgical vs conservative management

Higher PAS with surgery vs conservative
4 vs. 1
Larger tumour size with surgery vs conservative
2.6 vs. 1.8 cm
Comparable recovery of neuro-visual, radiological and hormonal outcomes

FPA management

CD and acromegaly required definitive treatment; prolactinomas effectively managed with oral cabergoline and glucocorticoids

PAS-matched macroadenomas (excluding prolactinoma): surgical vs conservative

Comparable neuro-deficit and hormonal recovery
  • Matched PAS cohorts

Original publication

Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center. Pituitary. Published 13 September 2024. doi:10.1007/s11102-024-01453-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.